Impact of preoperative COVID infection on the outcomes of planned curative-intent cancer surgeries in the second wave of the pandemic from a tertiary care center in India.
Saneya PandrowalaDeepak RamrajRavi ShankarSaumya ChopraAbhishek DasAseem MishraDurgatosh PandeyPublished in: Journal of surgical oncology (2021)
Our study included 432 preoperative patients of which 91 (21%) were COVID-19 positive. Amongst this cohort, 76% were operated and the morbidity and mortality were comparable to the COVID-19 negative cohort. Around 10% of the COVID-19 positive were lost to follow up and 10% had disease progression and were deemed palliative INTERPRETATION: SARS-CoV-2 infection has adversely impacted cancer care and a 2-week waiting period postinfection seems to be a safe interval in asymptomatic individuals to consider radical cancer surgery.
Keyphrases
- coronavirus disease
- sars cov
- papillary thyroid
- respiratory syndrome coronavirus
- tertiary care
- end stage renal disease
- prognostic factors
- squamous cell
- ejection fraction
- patients undergoing
- minimally invasive
- newly diagnosed
- chronic kidney disease
- palliative care
- peritoneal dialysis
- lymph node metastasis
- coronary artery bypass
- coronary artery disease
- childhood cancer
- young adults
- type diabetes
- weight loss
- percutaneous coronary intervention
- placebo controlled